FloxUrIDine.net
About FloxUrIDine.net
Floxuridine inhibits 96% of colorectal cancer cells (HT-96 cell line) versus 5-FU, which only inhibits 50%.1 Advances in how to optimize the clinical effects of this established chemotherapy agent have resulted in innovative treatment strategies. Clinical experience involving weekly high dose intravenous floxuridine regimens has demonstrated excellent results in treating pancreatic and colorectal cancers.
